NEW YORK (GenomeWeb News) – BioFocus today said that it has signed an agreement to offer ChanTest's cell line library and Channel Panel profiling services.

Saffron Walden, UK-based BioFocus said that the alliance will expand its offerings in the fields of ion channel, GPCR, and transporter targets for drug discovery. ChanTest's cell line library contains more than 200 products, BioFocus noted.

Chris Mathes, chief commercial officer of Cleveland-based ChanTest, said that the collaboration "fits well with ChanTest's integrated CRO strategy."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.